Endovascular Treatment of Aneurysms: Healing Mechanisms in a Swine Model Are Associated with Increased Expression of Matrix Metalloproteinases, Vascular Cell Adhesion Molecule-1, and Vascular Endothelial Growth Factor, and Decreased Expression of Tissue Inhibitors of Matrix Metalloproteinases

References

1. ↵
   Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol 2005;4:179–89

   PubMedWeb of Science
2. ↵
   Molyneux AJ, Kerr RS, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809–17

   CrossRefPubMedWeb of Science
3. Bavinzski G, Talazoglu V, Killer M, et al. Gross and microscopic histopathological findings in aneurysms of the human brain treated with Guglielmi detachable coils. J Neurosurg 1999;91:284–93

   PubMed
4. ↵
   Guglielmi GVF, Sepetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach. Part 1. Electrochemical basis, technique, and experimental results. J Neurosurg 1991;75:1–7

   CrossRefPubMedWeb of Science
5. ↵
   Hayakawa M, Murayama Y, Duckwiler GR, et al. Natural history of the neck remnant of a cerebral aneurysm treated with the Guglielmi detachable coil system. J Neurosurg 2000;93:561–68

   CrossRefPubMedWeb of Science
6. ↵
   Raymond J, Guilbert F, Weill A, et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke 2003;34:1398–403

   Abstract/FREE Full Text
7. ↵
   Peters DG KA, Feingold E, Heidrich-O'Hare E, et al. Molecular anatomy of an intracranial aneurysm: coordinated expression of genes involved in wound healing and tissue remodeling. Stroke 2001;32:1036–42

   Abstract/FREE Full Text
8. ↵
   Fujiwara NH, Kallmes DF. Healing response in elastase-induced rabbit aneurysms after embolization with a new platinum coil system. AJNR Am J Neuroradiol 2002;23:1137–44

   Abstract/FREE Full Text
9. ↵
   Raymond J, Ogoudikpe C, Salazkin I, et al. Endovascular treatment of aneurysms: gene expression of neointimal cells recruited on the embolic agent and evolution with recurrence in an experimental model. J Vasc Interv Radiol 2005;16:1355–63

   PubMed
10. ↵
    Ribourtout E, Raymond J. Gene therapy and endovascular treatment of intracranial aneurysms. Stroke 2004;35:786–93

    Abstract/FREE Full Text
11. ↵
    Dai D, Ding YH, Danielson MA, et al. Histopathologic and immunohistochemical comparison of human, rabbit, and swine aneurysms embolized with platinum coils. AJNR Am J Neuroradiol 2005;26:2560–68

    Abstract/FREE Full Text
12. ↵
    Murayama YVF, Suzuki Y, Akiba Y, et al. Development of the biologically active Guglielmi detachable coil for the treatment of cerebral aneurysms. Part II: An experimental study in a swine aneurysm model. AJNR Am J Neuroradiol 1999;20:1992–99

    Abstract/FREE Full Text
13. ↵
    German W, Black S. Experimental production of carotid aneurysms. N Engl J Med 1954;3:463–68
14. ↵
    Fontaine VJM, Houard X, Rossignol P, et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 2002;161:1701–10

    CrossRefPubMedWeb of Science
15. ↵
    Kuzuya MIA. Role of matrix metalloproteinases in vascular remodeling. J Atheroscler Thromb 2003;10:275–82

    PubMed
16. ↵
    Cho M, Reidy MA. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 2002;91:845–51

    Abstract/FREE Full Text
17. ↵
    George SJ, Zaltsman AB, Newby AC. Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein. Cardiovasc Res 1997;33:447–59

    Abstract/FREE Full Text
18. ↵
    Furman CLZ, Walsh K, Duverger N, et al. Systemic tissue inhibitor of metalloproteinase-1 gene delivery reduces neointimal hyperplasia in balloon-injured rat carotid artery. FEBS Lett 2002;531:122–26

    CrossRefPubMedWeb of Science
19. ↵
    George SJ BA, Angelini GD, Newby AC. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther 1998;5:1552–60

    CrossRefPubMedWeb of Science
20. ↵
    Murayama Y, Tateshima S, Gonzalez NR, et al. Matrix and bioabsorbable polymeric coils accelerate healing of intracranial aneurysms: long-term experimental study. Stroke 2003;34:2031–37

    Abstract/FREE Full Text
21. ↵
    Ding YH, Dai D, Lewis DA, et al. Angiographic and histologic analysis of experimental aneurysms embolized with platinum coils, Matrix, and HydroCoil. AJNR Am J Neuroradiol 2005;26:1757–63

    Abstract/FREE Full Text
22. ↵
    Koch AE, Halloran MM, Haskell CJ, et al. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995;376:517–19

    CrossRefPubMed
23. ↵
    Chu AJ. Tissue factor mediates inflammation. Arch Biochem Biophys 2005;440:123–32

    CrossRefPubMedWeb of Science
24. ↵
    Ravanti LHL, Hakkinen L, Larjava H, et al. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 1999;274:37292–300

    Abstract/FREE Full Text
25. ↵
    Ribourtout E, Desfaits AC, Salazkin I, et al. Ex vivo gene therapy with adenovirus-mediated transforming growth factor beta 1 expression for endovascular treatment of aneurysm: results in a canine bilateral aneurysm model. J Vasc Surg 2003;38:576–83

    CrossRefPubMedWeb of Science